Canada markets closed

Cellectar Biosciences, Inc. (CLRB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.1600-0.1400 (-4.24%)
At close: 04:00PM EDT
3.1700 +0.01 (+0.32%)
After hours: 05:37PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 118.30M
Enterprise Value 95.90M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)13.02
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3127.59%
S&P500 52-Week Change 326.49%
52 Week High 34.4500
52 Week Low 31.4300
50-Day Moving Average 33.4666
200-Day Moving Average 32.8784

Share Statistics

Avg Vol (3 month) 3963.02k
Avg Vol (10 day) 3666.4k
Shares Outstanding 535.85M
Implied Shares Outstanding 635.85M
Float 826.9M
% Held by Insiders 13.20%
% Held by Institutions 123.62%
Shares Short (Apr 30, 2024) 42.55M
Short Ratio (Apr 30, 2024) 42.83
Short % of Float (Apr 30, 2024) 48.06%
Short % of Shares Outstanding (Apr 30, 2024) 47.10%
Shares Short (prior month Mar 28, 2024) 42.53M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 17, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jul 22, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-91.47%
Return on Equity (ttm)-304.38%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -42.02M
Net Income Avi to Common (ttm)-50.98M
Diluted EPS (ttm)-3.0900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)40.03M
Total Cash Per Share (mrq)1.12
Total Debt (mrq)548.34k
Total Debt/Equity (mrq)2.10%
Current Ratio (mrq)2.54
Book Value Per Share (mrq)0.27

Cash Flow Statement

Operating Cash Flow (ttm)-38.55M
Levered Free Cash Flow (ttm)-15.53M